CBD (in the form of oils, creams, lotions, edibles and more) has entered mainstream America! Their presence has been noted in the fields of food and beverages, cosmetics, and pharmaceuticals. With projections for this industry to surpass $20 billion dollars by the year 2024, healthcare providers need to be aware of the ever-growing consumer usage, as well as the medical and legal implications for its users.
CBD is defined as cannabidiol. It is an active chemical in the Cannabis Sativa plant (also known as marijuana or hemp). While CBD is one of over 80 chemicals known as cannabinoids, by itself it does not cause a “high.” According to the World Health Organization, CBD exhibits no effects indicative of any abuse or dependence potential. Furthermore, to date, there is no evidence of public health-related problems associated with the use of pure CBD. The issue at hand is actually the origin of the CBD ingredients. While delta-9-tetrahydrocannabinol (THC) is the major active ingredient in marijuana, cannabidiol is also obtained from hemp, which contains only very small amounts of THC. The purpose of the continuing education program is to inform and educate healthcare providers on the various forms of CBD and their usage in mainstream medicine.
Upon completion of this course, participants will be able to:
Chapter 1: Introduction
Chapter 2: History of CBD
Chapter 3: The Endocannabinoid System
Chapter 4: Available Routes Of Administration
Maureen graduated nursing school in 1981 and has spent her years in the Emergency and Trauma field, including nursing positions as the Emergency Department Manager, Director of Staff Education, Trauma Coordinator, Cardiology Nurse Navigator, and Stroke Program Manager.Read Full Bio